20/20 GeneSystems, Weizmann's Yeda Collaborate on Lung Cancer Test | GenomeWeb

NEW YORK (GenomeWeb News) – Cancer diagnostics firm 20/20 GeneSystems and Yeda R&D, the technology transfer company of the Weizmann Institute of Science, today announced a collaboration aimed at commercializing a lung cancer test developed by researchers at Weizmann.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.